2020 JITC – Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms View PDF
2020 Accelerating the development of innovative cellular therapy products for the treatment of cancer Read more
2019 An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer View PDF
Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program View PDF
Use of FDA-Approved and Laboratory-Developed Tests in Advanced Non-Small Cell Lung Cancer: Results of a Retrospective Market Analysis View PDF
2016 Regulatory watch: Impact of breakthrough therapy designation on cancer drug development View PDF
2016 A Century of Medical Product Regulation: The Historic Framework for Medical Product Regulation View PDF
2013 Considerations for the successful co-development of targeted cancer therapies and companion diagnostics. View PDF
